MXCT Competitors & Alternatives

Compare MaxCyte Inc with similar stocks in the same industry

Medical Devices

MXCT

Main Stock
$1.37
+7.03%
Tradestie Score
44
Market Cap
$170.57M
Revenue Growth
48.7%
Analyst Upside
+199.8%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Other Cell Therapy Platform
Competitive Moat: Switching Cost
Core Technology Stack: Flow Electroporation, non-viral cell transfection
Major Customers 4
biopharma companies cell & gene therapy developers academic research institutions CROs/CDMOs
Critical Suppliers 2
reagent manufacturers precision electronics components
Direct Ecosystem Rivals 3

Top Competitors

62 stocks in Medical Devices
Company Price Market Cap P/E Score Action
PACB Pacific Biosciences of California, Inc.
$1.63
-7.39%
$414.51M - 55 Compare
TMCI Treace Medical Concepts, Inc. Common Stock
$4.31
-0.92%
$399.25M - 42 Compare
DCTH Delcath Systems Inc
$18.79
-2.34%
$376.05M 120.3 35 Compare
TCMD Tactile Systems Technology, Inc.
$25.60
-1.50%
$308.30M 25.2 40 Compare
CRBU Caribou Biosciences, Inc. Common Stock
$0.28
-8.44%
$210.46M - 45 Compare
SGHT Sight Sciences, Inc. Common Stock
$10.18
-4.14%
$175.43M - 43 Compare
RCEL Avita Medical, Inc. Common Stock
$15.62
-2.31%
$141.85M - 44 Compare
RLYB Rallybio Corporation Common Stock
$15.47
-0.32%
$21.68M 3.4 49 Compare
LZAGY LZAGY
$77.10
-2.58%
- - 49 Compare
SQZ SQZ
- - - - Compare

Data updated: Nov 22, 2026 | Industry: Medical Devices (SIC 8731)

62 stocks in this industry